About Us

We help patients to benefit from the scientific discoveries

The purpose of our work is to help people understand genetic background of the tumor and use this information to fight their cancer.

Our mission

We believe know that CLINICALLY VALUABLE INFORMATION FROM TUMOR GENOME IS WAITING TO BE DISCOVERED

By combining cutting-edge genome analysis with latest technological breakthroughs in AI we develop analytical tools delivering key answers to patients and clinicians.

Meet our team!

Our interdisciplinary team combines expertise in DNA chemistry and cell biology, with AI and machine learning to provide cutting-edge genome analysis and develop new approaches to personalized medicine. We work together toward a common vision. This interdisciplinary environment allows us to achieve the impossible.

Leadership

Pawel Zawadzki

CEO

After obtaining a triple PhD (chemistry, physics, biology) in 2009, Pawel spent 7 years at Oxford University studying DNA technology at Departments of Physics, Biochemistry and Oncology. In 2017 he established DNA repair focused research group at Adam Mickiewicz University. 2018, the MNM Diagnostics was born as a need to bring genomics directly to patient's bed by merging genomics with AI technologies.
PAWEL ZAWADZKI
CEO

Katarzyna Zawadzka

COO

A graduate of Biotechnology at Adam Mickiewicz University in Poznań. A long-time employee of the DNA Sequencing Laboratory. She continued her scientific career at the University of Oxford, where she gained knowledge, experience and scientific independence.
After returning to Poland in 2017, together with a group of enthusiastic specialists/scientists, she founded the company MNM Diagnostics, where she conducts research and analyses on personalized diagnostics and the selection of anti-cancer targeted therapies.
KATARZYNA ZAWADZKA
COO

Pawel Sztromwasser

Head of Technology Development

Obtained his Ph.D. in 2014 at the University of Bergen, Norway. His thesis focused on sensitivity analysis of high-throughput bioinformatics workflows. During the PhD at the Computational Biology Unit, and afterwards as a postdoc fellow at the Center for Medical Genetics (MGM) at the Haukeland University Hospital in Bergen, Pawel gained broad experience in deep sequencing (NGS) data analysis, high performance and cloud computing, software engineering, and human genetics. He had an opportunity to play a pivotal role in establishing a clinical whole-exome sequencing facility at the hospital, and after returning to Poland, in building a microbial sequencing facility at the National Veterinary Research Institute in Puławy, Poland. After acquiring a prestigious MSCA funded fellowship, and successful completion of the project at the Medical University of Lodz, Pawel joined MNM to pursue the ambisius mission of introducing whole-genome sequencing into routine patient diagnostics. His current main role is leading a team of programmers, bioinformaticians, and data-scientists that work side by side with geneticists and clinical scientists to develop cutting edge diagnostic tools in cancer, and to enable whole genome sequencing at a population scale.
PAWEL SZTROMWASSER
HEAD OF TECHNOLOGY DEVELOPMENT

Alicja Wozna

Head of R&D

A graduate of English Biotechnology at the Faculty of Biology, Adam Mickiewicz University in Poznań. In 2017, she started a modern interdisciplinary doctoral programm, combining the knowledge of molecualar biology, genomics and physics at the Faculty of Physics, AMU. During many internships in pioneering Polish and foreign institutions, e.g. École Normale Supérieure de Lyon, she gained expertise in applying sequencing methods to cancer research. Currently, she actively participates in the development of MNM Diagnostics as a Technology Development Manager, where she co-creates comprehensive AI-powered diagnostic tools for any type of cancer therapy. Alicja is passionate about sports and criminal literature.
ALICJA WOZNA
HEAD OF R&D

Michal Gorczewski

Head of Finance

A graduate of Edinburgh Napier University. He initially gained experience in international institutions such as the JP Morgan investment bank, RBS and State Street Bank and Trust. After returning to Poland, he worked in the investment industry, both in asset management and an insurance company, where he was the head of the investment department. In addition, he also worked in the e-commerce industry, where he was responsible for all activities of the finance department. At MNM Bioscience, he is responsible for the company’s financial activities and supports the company in developing on a new market and co-creates a strategy for further development.
MICHAL GORCZEWSKI
HEAD OF FINANCE

Scientific advisory board

Kelly Gordon, PhD

Owner, Boudicca Dx. LLC

Frances Toneguzzo, PhD

Executive VP at Nantkwest, Inc

Marcin Zukowski

Founder of Snowflake, Cloud computing

Career

Want to join us?  See current job offers!

Any questions?

Contact us

Contact page